Forefront Analytics, LLC
- SEC CIK
- 0001696802
- Latest filing
- Aug 12, 2026
Holdings changes from Q3 2023 to Q4 2023
Long positions only; new, added, reduced and sold out are based on share counts. Pick any two quarters this institution filed.
- New
- 4
- Est. +$5.19M
- Added
- 40
- Est. +$34.0M
- Reduced
- 21
- Est. −$28.0M
- Sold out
- 4
- Est. −$300.8K
Portfolio value went from $176.3M to $202.6M (+$26.2M (+14.9%)); positions from 67 to 67 (0).
All Q4 2023 holdingsAll Q3 2023 holdings
In the shares, value and % of portfolio columns, the top figure is Q4 2023 and the gray one below is Q3 2023. For stocks that split between the two quarters, Q3 2023 shares are converted at the split ratio before comparing.
| Security | Action | Shares | Share change | Value | Est. bought or sold | % of portfolio | Weight change (pp) |
|---|---|---|---|---|---|---|---|
| CTMXCytomX Therapeutics, Inc. | ReducedHistory | 30,84649,421 | −18,575−37.6% | $47.8K$63.8K | −$28.8K | <0.1%<0.1% | −0.01 |
| GERNGeron Corp | ReducedHistory | 28,31629,116 | −800−2.7% | $59.7K$61.7K | −$1.69K | <0.1%<0.1% | −0.01 |
| Achilles Therapeutics PLC00449L102 | Reduced– | 76,26978,169 | −1,900−2.4% | $67.8K$71.1K | −$1.69K | <0.1%<0.1% | −0.01 |
| MREOMereo BioPharma Group plc | ReducedHistory | 36,12465,649 | −29,525−45.0% | $83.4K$84.7K | −$68.2K | <0.1%<0.1% | −0.01 |
| NKTXNkarta, Inc. | ReducedHistory | 20,76739,657 | −18,890−47.6% | $137.1K$55.1K | −$124.7K | 0.1%<0.1% | +0.04 |
| ANNXAnnexon, Inc. | ReducedHistory | 31,28031,680 | −400−1.3% | $142.0K$74.8K | −$1.82K | 0.1%<0.1% | +0.03 |
| FUSNFusion Pharmaceuticals Inc. | ReducedHistory | 16,71533,685 | −16,970−50.4% | $160.6K$87.6K | −$163.1K | 0.1%<0.1% | +0.03 |
| UNHUnitedHealth Group Inc | ReducedHistory | 539542 | −3−0.6% | $285.6K$274.5K | −$1.59K | 0.1%0.2% | −0.01 |
| Tidal ETF Tr886364603 | Reduced– | 19,59320,174 | −581−2.9% | $374.8K$353.2K | −$11.1K | 0.2%0.2% | −0.02 |
| Vanguard Morningstar Small-Cap ETF922908751 | Reduced– | 4,40712,768 | −8,361−65.5% | $940.1K$2.41M | −$1.78M | 0.5%1.4% | −0.90 |
| Vanguard Morningstar Value ETF922908744 | Reduced– | 9,85111,412 | −1,561−13.7% | $1.47M$1.57M | −$233.4K | 0.7%0.9% | −0.17 |
| iShares Inc46434G509 | Reduced– | 64,52768,454 | −3,927−5.7% | $1.59M$1.62M | −$96.5K | 0.8%0.9% | −0.13 |
| Vanguard Intl Equity Index F922042676 | Reduced– | 55,83188,745 | −32,914−37.1% | $2.38M$3.45M | −$1.40M | 1.2%2.0% | −0.79 |
| Vanguard Real Estate ETF922908553 | Reduced– | 28,06865,058 | −36,990−56.9% | $2.48M$4.92M | −$3.27M | 1.2%2.8% | −1.57 |
| iShares Core S&P 500 ETF464287200 | Reduced– | 5,5415,620 | −79−1.4% | $2.65M$2.41M | −$37.7K | 1.3%1.4% | −0.06 |
| iShares Core High Dividend ETF46429B663 | Reduced– | 47,35561,409 | −14,054−22.9% | $4.83M$6.07M | −$1.43M | 2.4%3.4% | −1.06 |
| iShares Tr464288372 | Reduced– | 107,139145,421 | −38,282−26.3% | $5.04M$6.30M | −$1.80M | 2.5%3.6% | −1.08 |
| iShares MSCI USA Momentum Factor ETF46432F396 | Reduced– | 36,92285,406 | −48,484−56.8% | $5.79M$11.9M | −$7.61M | 2.9%6.8% | −3.91 |
| DBX ETF Tr233051200 | Reduced– | 165,727168,963 | −3,236−1.9% | $6.13M$5.90M | −$119.7K | 3.0%3.3% | −0.32 |
| Vanguard Ftse Developed Markets ETF921943858 | Reduced– | 190,312306,588 | −116,276−37.9% | $9.12M$13.4M | −$5.57M | 4.5%7.6% | −3.10 |
| Vanguard Ftse Emerging Markets ETF922042858 | Reduced– | 304,886407,309 | −102,423−25.1% | $12.5M$16.0M | −$4.21M | 6.2%9.1% | −2.87 |
Estimated amounts multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares): new positions use this quarter's value and sold-out positions last quarter's; positions reported only as principal (PRN) cannot be estimated. 13F shows only quarter-end holdings, not when trades happened or at what price.